Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | STAT6 | P42226 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.31 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2709448 | 0.98 | LMNA (0.32) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL13628690 | 0.95 | LMNA (0.31) | LMNA | |
| SCHEMBL4059325 | 0.93 | LMNA (0.32) | LMNA | |
| SCHEMBL4441622 | 0.86 | — | — | |
| SCHEMBL3844309 | 0.86 | ALDH1A1 (0.33) | LMNA | |
| SCHEMBL9877484 | 0.84 | GRIN2D (0.40) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL4059654 | 0.84 | — | — | |
| SCHEMBL3849632 | 0.84 | — | — | |
| SCHEMBL3849693 | 0.81 | LMNA (0.36) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA | |
| SCHEMBL548532 | 0.79 | LMNA (0.34) | SLC22A2SLC22A1GRIN2DGRIN3BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612155-B2 | Film forming composition, insulating film formed by use of the composition, and electronic device | FUJIFILM CORPORATION (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20070255003-A1 | Film forming composition, insulating film formed by use of the composition, and electronic device | FUJIFILM CORPORATION (JP) | 2007-11-01 | — | — | US | disclosed |
| US-20070255003-A1 | Film forming composition, insulating film formed by use of the composition, and electronic device | FUJIFILM CORPORATION (JP) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070255003-A1 | Film forming composition, insulating film formed by use of the composition, and electronic device | C1S, C1R, MLX | SLC22A2 4047/4885SLC22A1 3959/4885GRIN2D 1640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.